NNE capitalizes on new generation of drug factories
New possibilities help NNE Pharmaplan to continue its rapid growth in China, but the market also poses a number of challenges. Materials for pharmaceutical factories are not always what they seem, for example.
.jpg)
by Leonora Beck
Danish company NNE Pharmaplan is going to get a piece of the pie from the colossal growth in China. The company, which specializes in designing and building factories for drug manufacturing, is seeing growth rates of up to 20 % per year, and it looks like it will carry on for some time.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
